Introduction
============

The global CV risk should be assessed in each hypertensive individual, because it aids the professionals in therapeutic decision-making and allows prognostic analysis. The identification of hypertensive individuals prone to CV complications, especially myocardial infarction (MI) and stroke, is fundamental to a more aggressive therapy. Several algorithms and risk scores based on population studies were created in past decades,^[@r1]^ but, considering the lack of Brazilian data for a more accurate assessment of CV risk in the Brazilian population, the use of one single risk score should be avoided to support therapeutic decisions. Multifactorial models of risk stratification can be used for a more accurate individual risk classification.

Informing patients about their RF can improve the efficacy of pharmacological and non-pharmacological measures to reduce global risk. In addition, estimating indicators and using aging-related terms, such as \"vascular age\" or \"cardiometabolic age\", can aid in the strategy to change the RF.^[@r2],[@r3]^ See below some electronic addresses to estimate the vascular or cardiometabolic age recommended by American, Canadian and British societies.^[@r4]-[@r6]^

1.  [www.framinghamheartstudy.org/risk-functions/cardiovascular-disease/10-year-risk.php](http://www.framinghamheartstudy.org/risk-functions/cardiovascular-disease/10-year-risk.php)

    → supported by the National Heart, Lung, and Blood Institute and Boston University

2.  [www.nhs.uk/Conditions/nhs-health-check/Pages/check-your-heart-age-tool.aspx](http://www.nhs.uk/Conditions/nhs-health-check/Pages/check-your-heart-age-tool.aspx)

    → supported by the British Heart Foundation

3.  [cardiometabolicage.com](http://cardiometabolicage.com)

    → supported by the Canadian Institute for Health Research (CIHR) and McGill University

In clinical practice, CV risk stratification of hypertensive patients can be based on two different strategies. In the first, the assessment is aimed at determining the global risk directly related to hypertension, in which case the risk classification depends on BP levels, associated risk factors, TOD and presence of CVD or kidney disease. In the second strategy, the objective is to determine the risk of a certain individual to develop general CVD within 10 years. Although that form of assessment is not specific to hypertensive patients, since it can be applied to any individual aged 30-74 years, it is worth noting that AH is the major CVRF.

Additional cardiovascular risk stratification
---------------------------------------------

Only a small minority of hypertensive patients has only one BP elevation. Aimed at making risk stratification easier, the classification system in [Table 1](#t1){ref-type="table"}, contemplating only low, moderate and high risk, should be used. It is worth noting that the identification of previous CVD, kidney disease or DM considerably increases the risk of future CV events, independently of BP levels.^[@r7],[@r8]^

###### 

Risk stratification in hypertensive patients based on additional risk factors, presence of target-organ damage and cardiovascular or kidney disease

                                    SBP 130-139 orDBP 85-89   Stage 1 SAHSBP 140-159 or DBP 90-99   Stage 2 SAHSBP 160-179 or DBP 100-109   Stage 3 SAHSBP ≥ 180 or DBP ≥ 110
  --------------------------------- ------------------------- ------------------------------------- --------------------------------------- -----------------------------------
  No risk factor                    No additional risk        Low Risk                              Intermediate risk                       High Risk
  1-2 risk factors                  Low Risk                  Intermediate risk                     High Risk                               High Risk
  ≥ 3 risk factors                  Intermediate risk         High Risk                             High Risk                               High Risk
  Presence of TOD, CVD, CKD or DM   High Risk                 High Risk                             High Risk                               High Risk

SBP: systolic blood pressure; DBP: diastolic blood pressure; SAH: systemic arterial hypertension; CVD: cardiovascular disease; CKD: chronic kidney disease; DM: diabetes mellitus: TOD: target-organ damage.

The large majority of the hypertensive population has additional RF. Therefore, the CV risk assessment depends on information obtained from clinical history, physical examination and complementary tests, always aiming at:

-   Coexistence of other CVRF ([Table 2](#t2){ref-type="table"});

    Table 2Cardiovascular risk factors in the assessment of additional risk in hypertensives• Male sex• Age○ Men ≥ 55 years or women ≥ 65 years• History of premature CVD in first-degree relatives○ Men \< 55 years or women \< 65 years• Smoking habit• Dyslipidemia○ Total cholesterol \> 190 mg/dL and/or○ LDL-cholesterol \> 115 mg/dL and/or○ HDL-cholesterol \< 40 mg/dL in men or \< 46 mg/dL in women and/or○ Triglycerides \> 150 mg/dL• Insulin resistance○ Fasting serum glycemia: 100-125 mg/dL○ Oral glucose tolerance test: 140-199 mg/dL in 2 hours○ Glycated hemoglobin: 5.7 -- 6.4%• Obesity○ BMI ≥ 30 kg/m^2^○ AC ≥ 102 cm in men or ≥ 88 cm in women[^1]

-   Presence of hypertension TOD ([Table 3](#t3){ref-type="table"});

    Table 3Target-organ damage in the additional risk assessment of hypertensives• Left ventricular hypertrophy○ ECGI: Sokolow-Lyon index (SV~1~ + RV~5~or RV~6~) ≥ 35 mm○ ECGI: R aVL \> 11 mm○ ECGI: Cornell voltage \> 2440 mm\*ms○ ECHOI: LVMI \> 115 g/m^2^ in men or \> 95 g/m^2^ in women• Carotid IMT \> 0.9 mm or carotid plaque• Carotid-femoral PWV \> 10 m/s• ABI \< 0.9• Stage 3 chronic kidney disease (GFR 30-60 mL/min/1.73m^2^)• Albuminuria = 30 - 300 mg/24h or UACR = 30 - 300 mg/g[^2]

-   Diagnosis of CVD or kidney disease already established ([Table 4](#t4){ref-type="table"}).

    Table 4Established cardiovascular and kidney disease in the additional risk assessment of hypertensives.• Cerebrovascular disease○ Ischemic stroke○ Cerebral hemorrhage○ Transient ischemic attack• Coronary artery disease○ Stable or unstable angina○ Myocardial infarction○ Myocardial revascularization: percutaneous (angioplasty) or surgical○ Heart failure with reduced or preserved ejection fraction○ Symptomatic peripheral arterial disease of lower limbs○ Stage 4 chronic kidney disease (GFR \< 30 mL/min/1.73m^2^) or albuminuria \> 300 mg/24h○ Advanced retinopathy: hemorrhages, exudates, papilledema[^3]

Thus, to facilitate and speed the classification process of additional CV risk in the medical visit setting, the health professional in charge should follow the flowchart described in [Figure 1](#f1){ref-type="fig"}. It is worth noting that, in some cases, the initial classification can be modified according to the best or worst control of BP levels and RF.

Figure 1Flowchart of classification of additional CV risk for hypertensive patients. BP: blood pressure; CAD: coronary artery disease; HF: heart failure; PAD: peripheral arterial disease; CKD: chronic kidney disease; UACR: urine albumin/creatinine ratio; TOD: target-organ damage; LVH: left ventricular hypertrophy; PWV: pulse wave velocity; ABI: ankle-brachial index; SBP: systolic blood pressure; DBP: diastolic blood pressure. Risk factors: male sex, age \> 55 years (men) or \> 65 years (women), family history, smoking, dyslipidemia, obesity and insulin resistance.

Global cardiovascular risk stratification
-----------------------------------------

The CV risk stratification based on three steps has been recently recommended in the V Brazilian Guideline for Dyslipidemia and Atherosclerosis Prevention^[@r9]^ and the I Brazilian Guideline for Cardiovascular Prevention,^[@r10]^ and it can be adopted for hypertensive patients. The steps should be performed as follows.

Identification of atherosclerotic disease or of its equivalents
---------------------------------------------------------------

The first step to estimate CV risk is the identification of clinically evident or subclinical atherosclerotic disease, or of its equivalents, such as DM and CKD^[@r11]^ ([Table 5](#t5){ref-type="table"}). If positive, the individual is immediately classified as at high risk, because the chance of having the first or a new CV event within 10 years is greater than 20%. (GR: I; LE: A).

###### 

Definition of atherosclerotic disease and of its equivalents

  ---------------------------------------------------------------------------------------------------------------
  1\. Atherosclerotic disease (clinically evident): coronary, cerebrovascular or peripheral obstructive disease
  2\. Significant subclinical atherosclerosis documented by use of diagnostic methods
  3\. Arterial revascularization procedures
  4\. Types 1 and 2 diabetes mellitus
  5\. Chronic kidney disease
  6\. Family hypercholesterolemia
  ---------------------------------------------------------------------------------------------------------------

Global risk score analysis
--------------------------

When the individual does not meet any of the step 1 conditions, the next step is to estimate the Global Risk Score (GRS).^[@r6]^ The algorithm estimates the risk of having a CV event (CAD, stroke, PAD, HF) within 10 years. The distribution of points and percentage of risk is differentiated for women ([Tables 6A](#t6){ref-type="table"} and [6B](#t7){ref-type="table"}) and men ([Tables 7A](#t8){ref-type="table"} and [7B](#t9){ref-type="table"}). When the GRS is lower than 5%, the patient is classified as \'low risk\' (GR: A; LE: I), except those with a family history of premature CV disease, who are reclassified as \'intermediate risk\'. (GR: IIa; LE: B).

###### 

Points in the global risk score for women

  -------------------------------------------------------------------------------------
  Points   Age\      HDL-C   TC        SBP\            SBP\        Smoking   Diabetes
           (years)                     (non-treated)   (treated)             
  -------- --------- ------- --------- --------------- ----------- --------- ----------
  -3                                   \< 120                                 

  -2                 60+                                                      

  -1                 50-59                             \< 120                 

  0        30-34     45-49   \< 160    120-129                     No        No

  1                  35-44   160-199   130-139                                

  2        35-39     \< 35             140-149         120-129                

  3                          200-239                   130-139     Yes        

  4        40-44             240-279   150-159                               Yes

  5        45-49             280+      160+            140-149                

  6                                                    150-159                

  7        50-54                                       160+                   

  8        55-59                                                              

  9        60-64                                                              

  10       65-69                                                              

  11       70-74                                                              

  12       75+                                                                
  -------------------------------------------------------------------------------------

HDL-C: high-density lipoprotein cholesterol; TC: total cholesterol; SBP: systolic blood pressure.

###### 

Global CV risk for women according to the points obtained

  Points   Risk (%)   Points   Risk (%)
  -------- ---------- -------- ----------
  ≤ -2     \< 1       10       6.3
  -1       1.0        11       7.3
  0        1.2        12       8.6
  1        1.5        13       10.0
  2        1.7        14       11.7
  3        2.0        15       13.7
  4        2.4        16       15.9
  5        2.8        17       18.5
  6        3.3        18       21.6
  7        3.9        19       24.8
  8        4.5        20       28.5
  9        5.3        21+      \>30

###### 

Points in the global risk score for men

  -------------------------------------------------------------------------------------
  Points   Age\      HDL-C   TC        SBP\            SBP\        Smoking   Diabetes
           (years)                     (non-treated)   (treated)             
  -------- --------- ------- --------- --------------- ----------- --------- ----------
  -2                 60+               \< 120                                 

  -1                 50-59                                                    

  0        30-34     45-49   \< 160    120-129         \< 120      Não       Não

  1                  35-44   160-199   130-139                                

  2        35-39     \< 35   200-239   140-159         120-129                

  3                          240-279   160+            130-139               Sim

  4                          280+                      140-159     Sim        

  5        40-44                                       160+                   

  6        45-49                                                              

  7                                                                           

  8        50-54                                                              

  9                                                                           

  10       55-59                                                              

  11       60-64                                                              

  12       65-69                                                              

  13                                                                          

  14       70-74                                                              

  15+      75+                                                                
  -------------------------------------------------------------------------------------

HDL-C: high-density lipoprotein cholesterol; TC: total cholesterol; SBP: systolic blood pressure.

###### 

Global CV risk for men according to the points obtained

  Points   Risk (%)   Points   Risk (%)
  -------- ---------- -------- ----------
  ≤ -3     \< 1       8        6.7
  -2       1.1        9        7.9
  -1       1.4        10       9.4
  0        1.6        11       11.2
  1        1.9        12       13.2
  2        2.3        13       15.6
  3        2.8        14       18.4
  4        3.3        15       21.6
  5        3.9        16       25.3
  6        4.7        17       29.4
  7        5.6        18+      \> 30

Men with GRS between 5% and 20%, and women with GRS between 5% and 10% are initially considered at \'intermediate risk\'.^[@r12]^ (GR: I; LE: A).

Men with GRS \> 20% and women with GRS \> 10% are considered at \'high risk\' (GR: I; LE: A).

Risk reclassification based on the presence of aggravating factors
------------------------------------------------------------------

Patients at intermediate risk with the aggravating factors listed in [Table 8](#t10){ref-type="table"} are reclassified as at high risk.^[@r9],[@r13]-[@r15]^ (GR: IIa; LE: B).

###### 

Aggravating factors of CV risk

  -----------------------------------------------------------------------------------
  Aggravating factor                                               Recommendations\
                                                                   and evidence
  ---------------------------------------------------------------- ------------------
  1\. Family history of premature CAD in first-degree\             GR: IIa; LE: A
  relative, men \< 55 years or women \< 65 years                   

  2\. Diagnosis of MS according to the IDF criteria                 GR: IIb; LE: A

  3\. Microalbuminuria (30-300 mg/g creatinine) or\                GR: IIa; LE: B
  albuminuria (\> 300 mg/g creatinine)                             

  4\. LVH                                                          GR: IIa; LE: B

  5\. High-sensitive C-reactive protein \> 2 mg/L                  GR: IIa; LE: B

  6\. Carotid IMT \> 1.0 mm                                        GR: IIb; LE: B

  7\. Coronary calcium score \> 100 or \> 75^th^ percentile for\   GR: IIa; LE: A
  age and sex                                                      

  8\. ABI \< 0.9                                                   GR: IIa; LE: A
  -----------------------------------------------------------------------------------

CAD: coronary artery disease; MS: metabolic syndrome; IDF: International Diabetes Federation; LVH: left ventricular hypertrophy; IMT: intima-media thickness; ABI: ankle-brachial index.

The criteria used in the diagnosis of MS are shown in [Table 9](#t11){ref-type="table"}.

###### 

Diagnostic criteria for metabolic (syndrome defined with 3 or more criteria)15,16

  Criteria                                                    Definition
  ----------------------------------------------------------- -------------
  1\. Abdominal obesity                                        
  Men                                                         ≥ 94 cm
  Women                                                       ≥ 80 cm
  2\. HDL-cholesterol                                          
  Men                                                         \< 40 mg/dl
  Women                                                       \< 50 mg/dl
  3\. Triglycerides (or treatment for hypertriglyceridemia)   ≥ 150 mg/dl
  4\. BP (or treatment for arterial hypertension)              
  SBP and/or                                                  ≥ 130 mmHg
  DBP                                                         ≥ 85 mmHg
  5\. Glycemia (or treatment for DM)                          ≥ 100 mg/dl

BP: blood pressure; SBP: systolic blood pressure; DBP: diastolic blood pressure; DM: diabetes mellitus.

In addition, to facilitate the global CV risk determination in hypertensive patients, the flowchart in [Figure 2](#f2){ref-type="fig"} shows all steps necessary for the final classification.

Figure 2Flowchart to estimate global cardiovascular risk. FH: family history; CVD: cardiovascular disease.

In conclusion, so far no CV risk assessment way has been validated in Brazil. In addition, some young women tend to a risk estimate lower than the actual one, and older men are usually identified as at high risk, even with no relevant RF. Thus, the use of more than one classification allows better understanding of CV risk in hypertensive patients.

[^1]: CVD: cardiovascular disease; LDL: low-density lipoprotein; HDL: highdensity lipoprotein; BMI: body mass index; AC: abdominal circumference.

[^2]: ECG: electrocardiogram; ECHO: echocardiogram; IMT: intima-media thickness; LVMI: left ventricular mass index; PWV: pulse wave velocity; ABI: ankle-brachial index; GFR: estimated glomerular filtration rate; UACR: urine albumincreatinine ratio.

[^3]: GFR: estimated glomerular filtration rate.
